Catalog Research Community Tools AI Advisor Protocol Generator

Mechanism of Action Explorer

Explore 8 interactive SVG pathway diagrams showing how peptide compounds work at the molecular level. Visualize receptor binding, signaling cascades, and downstream biological effects.

Interactive molecular pathway diagrams showing how peptides work at the cellular level




Legend:
Activating
Inhibiting
Neutral/Transport
Node
Highlighted

Frequently Asked Questions

How do peptides work in the body?

Peptides are short chains of amino acids that act as signaling molecules by binding to specific receptors on cell surfaces. Once bound, they trigger intracellular signaling cascades that regulate processes like hormone release, tissue repair, immune modulation, and metabolism. Unlike small-molecule drugs that may interact with many targets, most peptides are highly selective for their receptor, which contributes to their favorable side-effect profiles. Their effects depend on the specific pathway they activate, such as the GH/IGF-1 axis, GLP-1 signaling, or BPC healing cascades.

What receptors do GH-releasing peptides bind to?

GH-releasing peptides (GHRPs) like Ipamorelin, GHRP-2, and GHRP-6 bind to the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor, located on pituitary somatotroph cells. This triggers a calcium influx that stimulates pulsatile GH release. GHRH analogs like CJC-1295 and Sermorelin bind to the GHRH receptor (GHRH-R) on the same cells but through a different signaling mechanism involving cAMP. When combined, GHRPs and GHRH analogs produce synergistic GH elevation because they activate complementary pathways on the same target cells.

What is the difference between GHRH and GHRP peptides?

GHRH (Growth Hormone Releasing Hormone) analogs like CJC-1295 and Sermorelin mimic the hypothalamic hormone that amplifies and sustains GH pulses by binding the GHRH receptor. GHRP (Growth Hormone Releasing Peptide) compounds like Ipamorelin and GHRP-6 mimic ghrelin and initiate new GH pulses by binding the GHS-R1a receptor. GHRH analogs increase the amplitude of existing pulses, while GHRPs increase the frequency. This is why they are often combined in research protocols -- the GHRP initiates the pulse and the GHRH analog amplifies it, resulting in significantly greater GH output than either alone.

Related Tools & Resources

๐Ÿ“Š Effect Matrix โš–๏ธ Compare Compounds ๐Ÿ”ฌ Research Library ๐Ÿงช Clinical Trial Tracker

Popular Protocols

Semaglutide Protocol Tirzepatide Protocol BPC-157 Protocol MK-677 Protocol TB-500 Protocol Ipamorelin Protocol CJC-1295 + Ipamorelin Protocol GHK-Cu Protocol Peptide Catalog
Share & Save
๐• Share on Twitter ๐Ÿ“ฑ Share on Reddit ๐Ÿ’ฌ WhatsApp โœ‰๏ธ Email ๐Ÿ”— Copy Link ๐Ÿ–จ๏ธ Print / Save PDF โ˜… Save to Favorites
โ˜… OFFICIAL SPONSOR
BioRoot AI
Free Functional Assessment
AI-powered root cause analysis & care plan
Start Free
Paid partnership ยท Learn more
Editorial Policy Medical Disclaimer Privacy Policy Terms of Service Site Map

© 2026 Path to Peptides™. For research and educational purposes only. Not medical advice.

Some links on this site may earn a commission at no cost to you.